SANOFI trade ideas
Sanofi India Ltd
Longterm investors can enter in this counter around 5100 - 5400 levels
Market Cap
₹ 12,578 Cr.
Current Price
₹ 5,462
High / Low
₹ 7,600 / 4,606
Stock P/E
29.8
Book Value
₹ 298
Dividend Yield
3.06 %
ROCE
71.1 %
ROE
51.5 %
Face Value
₹ 10.0
Price to book value
18.4
Intrinsic Value
₹ 1,570
PEG Ratio
3.27
Price to Sales
5.74
Debt
₹ 22.1 Cr.
Debt to equity
0.03
Int Coverage
363
Reserves
₹ 662 Cr.
Promoter holding
60.4 %
Pledged percentage
0.00 %
EPS last year
₹ 262
Net CF
₹ -612 Cr.
Price to Cash Flow
54.4
Free Cash Flow
₹ 221 Cr.
OPM last year
28.2 %
Return on assets
31.2 %
Industry PE
41.4
Sales growth
-9.19 %
Sanofi can ShineSanofi India Ltd. engages in the manufacturing and distribution of pharmaceutical drugs. It focuses on the following therapeutic areas: diabetes, cardiology, consumer healthcare, hospitals, central nervous system, and antihistamines.
Sanofi India Ltd. CMP is 7048.85. The positive aspects of the company are Company with No Debt, Company with Zero Promoter Pledge, Mutual Funds Increased Shareholding over the Past Two Months. The Negative aspects of the company are high Valuation (P.E. = 30.7), Stocks Underperforming their Industry Price Change in the Quarter, Declining profits every quarter for the past 3 quarters and Increasing Trend in Non-Core Income.
Entry can be taken after closing above 7066 Targets in the stock will be 7304 and 7434. The long-term target in the stock will be 7618. Stop loss in the stock should be maintained at Closing below 6679 or 6300 depending on your risk taking ability.
Disclaimer: The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
Sanofi india can again make a rally?Cmp6650
stop6300
target 7k++
risky bet
cicuit stock
result coming soon!
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines
only for study purpose
not a buy or sell recomendation
SANOFI - Inverse Head & Shoulder BreakoutI have been trading breakouts on weekly charts from a long time already.
And I can tell they are the most peaceful thing in the market.
Though, nothing is guaranteed in this world, this breakout gives a place to participate with low risk area.
As you can see Inverse Head & Shoulder breakout gives a small stop loss and that is why they are the most favorable.
Let me know your views.
Sanofi India Ltd.*Sanofi India Ltd*
C&H Formation on Monthly Basis underway.
BO >8982/9281/9374 Needed & To be Watched. Else can get trapped.
Strong Vol. Consolidation. Continued Traction required.
RSI: 1H >D =W <M. All in Bullish Zone.
*Trail SL with Upside*
*Book Profit as per Risk Appetite*
*Do Your Own Research as well. This is an Opinion*
*_Happy Investing_*🤓
sanofiPharmaceutical firm Sanofi India secured its board's approval to demerge its consumer health business into its wholly owned subsidiary, Sanofi Consumer Healthcare India, according to a Wednesday release.
Upon completion of the proposed demerger, Sanofi India shareholders will be entitled to receive 1:1 Sanofi Consumer Healthcare India equity shares of 10 Indian rupees each, for each equity share owned.
The new unit will be listed on local bourses, BSE and the National Stock Exchange, subject to necessary approvals.
SANOFI LONG TERM BUYINGPreviously SANOFI was consolidating in weekly chart.
Now there is a breakout on upper side.
There is 1:14 Risk Reward Long Term Trade Opportunity.
Pros:
1. Very High RR Ratio 1:14
2. Expected Waiting Period is around 8-16 Months
3. Target it 50% +
4. Very High Probability as its fundamentally good stock
Cons:
1. Gave bad results in recent Quarterly Results
We can take 4% Risk to Gain 50% Profit which I consider very great trade.
update on Sanofi, very bullish!!!1. rsi going up
2. macd about to cross its lines
3. price getting consolidated
4. correction waves are done
5. volume increasing
i have no reason why sanofi will fall.
one can take trade during this time, and do swing trade TARGET- above 7800.
one can even go long term, as this is the most bottom part of Sanofi, and you will getting benefitted later.
BUY AND HOLD.
Sanofi bull run about to comewhen the waves get completed one could make profits within a short duration.
Sanofi is a great company with a good fundamentals, due to FII selling heavily and earnings not reaching the estimate, it has corrected a lot. its gaining volume, and RSI indicator also showing a bull trend coming nearer.
SANOFI INDIA LTD (LONG)Taking support near 7600 - 7700.
now all set to move up.
move up will be gradual.
it should cross 10k in 1-2 years.
following the channel upside.
BUY near 7789.
BUY more near 7626 to average out.
TGT 8396 - 8740.
SL 7482.
Please correlate yourself also on charts. this is for educational purpose only. must consult with your financial advisor before investing.